Try our Advanced Search for more refined results

Lupin Pushes Fed. Circ. To Reconsider Fortamet Injunction

By Erica Teichert (April 18, 2012, 8:02 PM EDT) -- Drugmaker Lupin Ltd. urged the Federal Circuit on Wednesday to reverse a preliminary injunction barring the company from selling its generic version of the diabetes drug Fortamet, saying its previous remand of the injunction had no effect on the lower court....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!